(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

COMPOSTOS DE ANANDAMIDA

ArquivadaInvention PatentPCT · US2020013150
Talk to an expert

Application data

Number

112021013515

Type

Invention Patent

Filing

01/10/2020

Publication

09/14/2021

PCT

US2020013150
View on INPI

Progress at the INPI

  1. Filing01/10/20
  2. Publication09/14/21
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 01/10/2020 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 07/11/2023. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

TRAVECTA THERAPEUTICS PTE. LTD.

SG

Inventors

D. S. (pessoa física)

SG

M. A. (pessoa física)

SG

S. M. (pessoa física)

CN

Technical data

IPC Classification

A61K 31/6615A61P 25/04C07C 233/16C07F 9/10

Priority claims

US

62/790,787 · 01/10/2019

Abstract

COMPOSTOS DE ANANDAMIDA.A presente invenção refere-se a compostos de anandamida e 2-araquidonil glicerol úteis para o tratamento de uma doença ou transtorno em um indivíduo que precisa do mesmo. Também são fornecidas composições farmacêuticas que compreendem os compostos e métodos de tratamento de doenças ou transtornos.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

07/11/2023

RPI 2740

Arquivamento - Art. 33 da LPI

#11.1

04/25/2023

RPI 2729

Notificação de entrada na fase nacional - PCT

#1.3

09/14/2021

RPI 2645

Alteração de dados cadastrais

#1.1

07/20/2021

RPI 2637

Related

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.